The unrelenting fungemia: Use of flucytosine combination therapy for disseminated Candidozyma auris infection with mitral valve endocarditis in a patient unable to undergo valve replacement
The unrelenting fungemia: Use of flucytosine combination therapy for disseminated Candidozyma auris infection with mitral valve endocarditis in a patient unable to undergo valve replacement. // IDCases. – URL: https://www.sciencedirect.com/science/article/pii/S2214250926003495?dgcid=rss_sd_all
The unrelenting fungemia: Use of flucytosine combination therapy for disseminated Candidozyma auris infection with mitral valve endocarditis in a patient unable to undergo valve replacement. IDCases. https://www.sciencedirect.com/science/article/pii/S2214250926003495?dgcid=rss_sd_all
“The unrelenting fungemia: Use of flucytosine combination therapy for disseminated Candidozyma auris infection with mitral valve endocarditis in a patient unable to undergo valve replacement.” IDCases.
@article{article48170,
title = {The unrelenting fungemia: Use of flucytosine combination therapy for disseminated Candidozyma auris infection with mitral valve endocarditis in a patient unable to undergo valve replacement},
journal = {IDCases},
url = {https://www.sciencedirect.com/science/article/pii/S2214250926003495?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...